Laboratory diagnosis of human immunodeficiency virus infection

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 13, Issue 2, 2004, Pages 43-49

  Luft, Sandi ^a   Seme, Katja ^b   Poljak, Mario ^b,c  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c Department of Microbiology ^*

Author keywords

Antibodies; Antigens; HIV; Laboratory diagnosis; Review

Indexed keywords

ANTIRETROVIRUS AGENT; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

AGGLUTINATION TEST; DIAGNOSTIC ACCURACY; DISEASE COURSE; DRUG RESPONSE; ENZYME IMMUNOASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; LABORATORY DIAGNOSIS; NONHUMAN; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PROGNOSIS; QUANTITATIVE ANALYSIS; REVIEW; SCREENING TEST; SEROCONVERSION; SEROLOGY; VIRUS CULTURE; VIRUS DIAGNOSIS; VIRUS LOAD; WESTERN BLOTTING;

EID: 3142714322     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. th ed, ASM Press, Washington 2003, 1253-81.
2. Schacker T. Primary HIV infection. Early diagnosis and treatment are critical to outcome. Postgrad Med 1997; 102: 143-6, 149-51.
3. Clark SJ, Saag MS, Decker WD, et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 1991; 324: 954-60.
4. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991; 324: 961-4.
5. Horsburgh CR Jr, Ou CY, Jason J, et al. Duration of human immunodeficiency virus infection before detection of antibody. Lancet 1989; 334: 637-40.
6. Gaines H, Non Sydow M, Sonnerborg A, et al. Antibody response in primary human immunodeficiency virus infection. Lancet 1987; 329: 1249-53.
7. Allain JP, Laurian Y, Paul DA, Senn D. Serological markers in early stages of human immunodeficiency virus infection in hemophiliacs. Lancet 1986; 328: 1233-6.
8. Yilmaz G. Diagnosis of HIV infection and laboratory monitoring of its therapy. J Clin Virol 2001; 21: 187-96.
9. Centers for Disease Control. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infection. MMWR Morb Mortal Wkly Rep 1989; 38: Suppl 7: 1-7.
10. Gurtler L. Difficulties and strategies of HIV diagnosis. Lancet 1996; 348: 176-9.
11. Bylund DJ, Ziegner UH, Hopper DG. Review of testing for human immunodeficiency virus. Clin Lab Med 1992; 12: 305-33.
12. Farzadegan H, Taylor E, Hardy W, et al. Performance of serological assays for early detection of human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 1989; 27: 1882-4.
13. Farzadegan H, Pols MA, Wolinsky SM, et al. Loss of human immunodeficiency virus type a (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the multicenter AIDS cohort study. Ann Inter Med 1998; 108: 787-90.
14. Ayres L, Avillez F, Garcia-Benito A, et al. Multicenter evaluation of a new recombinant enzyme immunoassay for the combined detection of antibody to HIV-1 and HIV-2. AIDS 1990; 4: 131-8.
15. Poljak M, Babič D, Seme K. Retrospective evaluation of the Vidas HIV DUO test for simultaneous detection of anti-HIV antibody and p24 antigen. Acta Dermatoven APA 2002; 11: 11-3.
16. Gurtler LG, Zekeng L, Tsaque JM, et al. HIV-1 subtype O: Epidemiology, pathogenesis, diagnosis, and perspectives of the evolution of HIV. Arch Virol Suppl 1996; 11: 195-202.
17. Davey RT Jr, Deyton LR, Metcalf JA, et al. Indeterminate Western blot patterns in a cohort of individuals at high risk for human immunodeficiency virus (HIV-1) exposure. J Clin Immunol 1992; 12: 185-92.
18. Nadal D, Böni J, Kind C, et al. Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. J Infect Dis 1999; 180: 1089-95.
19. Borkowsky W, Krasinski K, Paul D, et al. Human immunodeficiency virus type 1 antigenemia in children. J Pediatr 1989; 114: 940-5.
20. Andiman WA, Silva TJ, Shapiro TD, et al. Predictive value of the human immunodeficiency virus 1 antigen test in children born to infected mothers. Pediatr Infect Dis J 1992; 1: 436-40.
21. Burgard M, Mayaux MJ, Blarche S, et al. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. The HIV infection in newborns French collaborative study group. N Engl J Med 1992; 327: 1192-7.
22. Corrigan GE, Al-Khalili L, Malmsten A, et al. Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strains. AIDS Res Hum Retroviruses 1998; 14: 347-52.
23. Fiscus SA, Welles SL, Spector SA, Lathley JL. Length of incubation time for human immunodeficiency virus cultures. J Clin Micriobiol 1995; 33: 246-7.
24. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995; 267: 483-9.
25. Brown AE, Jackson B, Fuller SA, et al. Viral RNA in the resolution of human immunodeficiency virus type 1 diagnostic serology. Transfusion 1997; 37: 926-9.
26. Cassol S, Butcha A, Kinard S, et al. Rapid screening for early detection of mother-to-child transmission of human immunodeficiency virus type 1. J Clin Microbiol 1994; 32: 2641-5.
27. Barlow KL, Tosswill JH, Parry JV, Clewley JP. Performance of the Amplicor human immunodeficiency virus type 1 PCR and analysis of specimen with false-negative results. J Clin Microbiol 1997; 35: 2846-53.